Effect of repeated gaboxadol administration on night sleep and next-day performance in healthy elderly subjects

Neuropsychopharmacology

Volumn 30, Issue 4, 2005, Pages 833-841

  Mathias, Stefan ^a   Zihl, Josef ^a   Steiger, Axel ^a   Lancel, Marike ^a  

^a MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

Author keywords

EEG spectral analysis; Gaboxadol; Hypnotics; Performance; Sleep stages

Indexed keywords

GABOXADOL; PLACEBO;

ADULT; AGED; AROUSAL; ARTICLE; ATTENTION; CLINICAL TRIAL; COGNITION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG SAFETY; FEMALE; HUMAN; MALE; MEMORY; PERFORMANCE; POLYSOMNOGRAPHY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SLEEP; SLOW WAVE SLEEP; STATISTICAL SIGNIFICANCE; VISUAL MEMORY; WAKEFULNESS; WORD RECOGNITION;

ACTIVITIES OF DAILY LIVING; AGED; ATTENTION; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; ELECTROENCEPHALOGRAPHY; FEMALE; GABA AGONISTS; HUMANS; HYPNOTICS AND SEDATIVES; ISOXAZOLES; MALE; MEMORY; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PLACEBO EFFECT; SLEEP; SLEEP INITIATION AND MAINTENANCE DISORDERS; TREATMENT OUTCOME; WAKEFULNESS;

EID: 15444366196     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.npp.1300641     Document Type: Article

References (47)

1. Bäumler G (1985). Farbe-Wort-Interferenztest (FWIT) nach J.R. Stroop. Verlag für Psychologie: Göttingen, Toronto, Zürich.
2. Benton AL, Hamsher K de S, Varney NR, Spreen O (1983). Contributions to Neuropsychological Assessment. Oxford University Press: New York.
3. Billiard M, Besset A, de Lustrac C, Brissaud L (1987). Dose-response effects of zopiclone on night sleep and on nighttime and daytime functioning. Sleep 10(Suppl 1): 27-34.
4. Bliwise DL (1993). Sleep in normal aging and dementia. Sleep 16: 40-81.
5. Brickenkamp R (1995). Aufmerksamkeitsbelastungstest 'd2', erweiterte und neu gestaltete Auflage. Diagnostica 41: 291-296.
6. Broadhurst A, Cushnaghan RC (1987). Residual effects of zopiclone (imovane). Sleep 10(Suppl 1): 48-53.
7. Costa e Silva JA, Chase M, Sartorius N, Roth T (1996). Special report from a symposium held by the World Health Organization and the World Federation of Sleep Research Societies: an overview of insomnias and related disorders - recognition, epidemiology, and rational management. Sleep 19: 412-416.
8. Dijk DJ, Beersma DGM, van den Hoofdakker RH (1989). All night spectral analysis of EEG sleep in young and middle-aged male subjects. Neurobiol Aging 10: 677-682.
9. Edinger JD, Glenn DM, Bastian LA, Marsh GR (2000). Slow-wave sleep and waking cognitive performance II: findings among middle-aged adults with and without insomnia complaints. Physiol Behav 70: 127-134.
10. Ehlers CL, Kupfer DJ (1989). Effects of age on delta and REM sleep parameters. Electroencephalogr Clin Neurophysiol 72: 118-125.
11. A agonist THIP produces slow wave sleep and reduces spindling activity in NREM sleep in humans. Psychopharmacology 130: 285-291.
12. Feinberg I, Koresko RL, Heller N (1967). EEG sleep patterns as a function of normal and pathological aging in man. J Psychiatr Res 5: 107-144.
13. Gorenstein C, Gentil V (1983). Residual and acute effects of flurazepam and triazolam in normal subjects. Psychopharmacology 80: 376-379.
14. Greenblatt DG, Allen MD (1978). Toxicity of nitrazepam in the elderly: a report from the Boston Collaborating Drug Surveillance Program. Br J Clin Pharmacol 5: 407-413.
15. Greenblatt DG, Allen MD, Shader RI (1977). Toxicity of high dose flurazepam in the elderly. Clin Pharmacol Ther 21: 355-361.
16. Harrison C, Subhan Z, Hindmarch I (1985). Residual effects of zopiclone and benzodiazepine hypnotics on psychomotor performance related car driving. Drugs Exp Clin Res XI: 823-829.
17. Hedden T, Gabrieli JDE (2004). Insight into the ageing mind: a view from cognitive neuroscience. Nat Neurosci 5: 87-97.
18. Hemmeter U, Müller M, Bischof R, Annen B, Holsboer-Trachsler E (2000). Effect of zopiclone and temazepam on sleep EEG parameters, psychomotor and memory functions in healthy elderly subjects. Psychopharmacology 147: 384-396.
19. Hindmarch I, Fairweather DB (1994). Assessing the residual effects of hypnotics. Acta Psychiat Belg 94: 88-95.
20. Hindmarch I, Ott H (1984). Sleep, benzodiazepines and performance: issues and comments. In: Hindmarch I, Ott H, Roth T (eds). Psychopharmacology Supplement 1. Springer-Verlag: Berlin. pp 194-202.
21. Hindmarch I, Patat A, Stanley N, Paty I, Rigney U (2001). Residual effects of zaleplon and zolpidem following middle of the night administration five hours to one hour before awakening. Hum Psychopharmacol Clin Exp 16: 159-167.
22. Janke W, Erdmann G, Hüppe M, Debus G (1999). Befindlichkeitsskalierung anhand von Kategorien und Eigenschaftswörtern (BSKE). Unpublished Manual. Institut für Psychologie der Universität: Würzburg.
23. Kunz D, Herrmann WM (2000). Sleep-wake cycle, sleep-related disturbances, and sleep disorders: a chronobiological approach. Comprehens Psychiatry 41: 104-115.
24. A agonist THIP increases non-REM sleep and enhances non-REM sleep-specific delta activity in the rat during the dark period. Sleep 20: 1099-1104.
25. A receptors in the regulation of sleep: initial sleep responses to peripherally administered modulators and agonists. Sleep 22: 33-42.
26. A) agonist 4,5,6,7-tetrahydroisoxazolo(4,5-c)pyridin-3-ol persistently increases sleep maintenance and intensity during chronic administration to rats. J Pharmacol Exp Ther 293: 1084-1090.
27. A agonist THIP (gaboxadol) increases non-REM sleep and enhances delta activity in the rat. Neuroreport 7: 2241-2245.
28. Lancel M, Wetter TC, Steiger A, Mathias M (2001). Effect of the GABAA agonist gaboxadol on nocturnal sleep and hormone secretion in healthy elderly subjects. Am J Physiol 281: E130-E137.
29. Landolt HP, Dijk DJ, Achermann P, Borbély AA (1996). Effect of age on the sleep EEG: slow-wave activity and spindle frequency activity in young and middle-aged men. Brain Res 738: 205-212.
30. Lezak M (1995). Neuropsychological Assessment, 3rd edn. Oxford University Press: New York, Oxford.
31. A agonist gaboxadol improves the quality of post-nap sleep. Psychopharmacology 157: 299-304.
32. Miles LE, Dement WC (1980). Sleep and aging. Sleep 3: 119-220.
33. Monane M (1992). Insomnia in the elderly. J Clin Psychiatry 53(Suppl 6): 23-28.
34. Mooris JC, Heyman A, Mohs RC, Hughes JP, van Belle G, Fillenbaum G et al (1989). The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer's disease. Neurology 39: 1159-1165.
35. Ohyon MM, Vecchierini MF (2002). Daytime sleepiness and cognitive impairment in the elderly population. Arch Int Med 162: 201-208.
36. Parrino L, Terzano MG (1996). Polysomnographic effects of hypnotic drugs. A review. Psychopharmacology 126: 1-16.
37. Partinen M (1993). Sleep problems in the elderly: epidemiology overview. In: Albarede JL, Morley JE, Roth T, Vellas BJ (eds). Sleep Disorders and Insomnia in the Elderly, Vol 7, Facts and Research in Gerontology. Serdi: Paris. pp 11-16.
38. Rechtschaffen A, Kales A (1968). A Manual of Standardized Terminology, Techniques and Scoring System for Sleep Stages of Human Subjects. National Institute of Health Publications, US Government Printing Office: Washington, DC.
39. Roehrs T, Kribbs N, Zorick F, Roth T (1986). Hypnotic residual effects of benzodiazepines with repeated administration. Sleep 9: 309-316.
40. Roth T, Roehrs T, Vogel G (1995). Zolpidem in the treatment of transient insomnia: a double-blind, randomized comparison with placebo. Sleep 18: 246-251.
41. Scharf MB, Mayleben DW, Kaffeman M, Krall R, Ochs R (1991). Dose response effects of zolpidem in normal geriatric subjects. J Clin Psychiatry 52: 77-83.
42. 14C- labelled compound. Acta Pharmacol Toxicol 49: 116-124.
43. Seppala M, Rajala T, Sourander L (1993). Subjective evaluation of sleep and the use of hypnotics in nursing homes. Aging 5: 199-205.
44. Stip E, Furlan M, Lussier I, Bourgouin P, Elie R (1999). Double-blind, placebo-controlled study comparing effects of zopiclone and temazepam on cognitive functioning of insomniacs. Hum Psychopharmacol Clin Exp 14: 253-261.
45. Troy SM, Lucki I, Unruh MA, Cevallos WH, Leister CA, Martin PT et al (2000). Comparison of the effects of zaleplon, zolpidem, and triazolam on memory, learning, and psychomotor performance. J Clin Psychopharmcol 20: 328-337.
46. Tuokko H, Frerichs RJ (2000). Cognitive impairment with no dementia (CIND): longitudinal studies, the findings, and the issues. Clin Neuropsychologist 14: 504-525.
47. Walsh J, Ustun TB (1999). Prevalence and health consequences of insomnia. Sleep 22(Suppl 3): S427-S436.